Abstract:Elevated levels of the excitotoxic amino acids, glutamate and aspartate, have been implicated in the pathogenesis of neuronal injury and death induced by cerebral ischemia. This study evaluated the contribution of reversed high-affinity, Na(+)-dependent, glutamate transport to the ischemia-evoked release of glutamate and aspartate using DL-threo-beta-benzyloxyaspartate (DL-TBOA), a newly developed competitive, non-transported blocker of the EAAT 1-3 transporters. Changes in the extracellular levels of these and other amino acids, and of glucose and lactate in cerebral cortical superfusates during four-vessel occlusion-elicited global cerebral ischemia were examined using a cortical window technique. Basal and ischemia-evoked amino acid, glucose and lactate efflux were compared in control versus DL-TBOA (100 microM; applied topically for 35 min prior to ischemia) animals. Twenty minutes of ischemia caused large increases in aspartate, glutamate, GABA and taurine effluxes into cortical superfusates, with non-significant effects on the efflux of glycine, glutamine, alanine and serine. Application of DL-TBOA caused a 2-fold increase in basal, preischemic, extracellular glutamate levels, but did not affect those of the other compounds. In the presence of DL-TBOA, ischemia-evoked release of aspartate, glutamate, taurine and glutamine was significantly reduced; that of the other amino acids was not affected. The ischemia-evoked declines in glucose were significantly attenuated, and lactate release was enhanced above that in control animals. The amino acid data are interpreted as indicating that aspartate and glutamate releases were reduced as a consequence of DL-TBOA inhibition of reversed transport by high-affinity, Na-dependent carriers, predominantly involving the glial EAAT 2 transporter. The reduction in ischemia-evoked taurine release is interpreted as being due to a decrease in cell swelling prior to and during the initial phase of ischemia due to reduced entry of the Na(+), and other ions, associated with a decreased glutamate uptake. Glucose-sparing and availability for lactate formation would also result from a reduced glutamate/Na(+) uptake. These results indicate that reversed transport, primarily from glial cells by the EAAT 2 carrier, is responsible for a substantial (42 and 56%) portion of the ischemia-evoked increase in extracellular glutamate and aspartate levels, respectively. As a potent, competitive, non-transported blocker of high-affinity, Na(+)-dependent, glutamate transporters, DL-TBOA promises to be a valuable new compound for the study of glutamatergic mechanisms.

Effect of Glutamate Transporter Inhibitor TBOA on Seizure Relative to Global Cerebral Ischemia

Effect of diazoxide on regulation of vesicular and plasma membrane GABA transporter genes and proteins in hippocampus of rats subjected to picrotoxin-induced kindling.

Chronic Trigeminal Nerve Stimulation Protects Against Seizures, Cognitive Impairments, Hippocampal Apoptosis, and Inflammatory Responses in Epileptic Rats

Effects of L-tetrahydropalmatine on Concentrations of Neurotransmitter Amino Acids in Mice with Cerebral Ischemia

The Expression of Glutamate Transporters in Chest Compression-Induced Audiogenic Epilepsy: a Comparative Study

Neurochemical Effects of Exercise and Neuromuscular Electrical Stimulation on Brain after Stroke: A Microdialysis Study Using Rat Model

Effects of L-Tetrahydropalmatine on Electrophysiological Changs Induced by Ischemia in Hippocampal Slices

The effect of cationic albumin-conjugated PEGylated tanshinone IIA nanoparticles on neuronal signal pathways and neuroprotection in cerebral ischemia.

Hyperbaric oxygen treatment attenuated the decrease in regional glucose metabolism of rats subjected to focal cerebral ischemia: a high resolution positron emission tomography study.

Investigation into Antiepileptic Effect of Ganoderic Acid A and Its Mechanism in Seizure Rats Induced by Pentylenetetrazole

Involvement of monocarboxylate transporters in the cross-tolerance between epilepsy and cerebral infarction: A promising choice towards new treatments

The expression of glutamate transporters in global ischemic brain in rats

The changes of GAP-43 and NCAM expression in hippocampus of temporal lobe epilepsy rats induced by kainic acid and the therapeutic roles of topiramate

Effect of oxcarbazepine on cortical excitability in patients with epilepsy

Effect of Treadmill Preconditioning on the Glutamate Content and Its Receptor Gene Expression in Striatum of Rats with Cerebral Ischemia

Expression and Functions of Glutamate and Γ‑aminobutyric Acid Transporters in Ischemic Models.

Pre-ischemic treadmill training induces tolerance to brain ischemia: involvement of glutamate and ERK1/2.

Glutamate transporters regulate excitability in local networks in rat neocortex

Transporter Reversal As a Mechanism of Glutamate Release from the Ischemic Rat Cerebral Cortex: Studies with DL-threo-beta-benzyloxyaspartate.

Effects of Different Doses of Topiramate on Expression of NCAM and GAP- 43 Mrna in Hippocampus of Rats with Epilepsy

Influence of topiramate on amino acids neurotransmitter of cerebral cortex in rats with cerebral ischemia reperfusion injury and neuroprotective effect